EDG-3 Activators
SEE ALSO...
Items 1 to 10 of 13 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
D-erythro-Sphingosine-1-phosphate, classified as an EDG-3, exhibits intriguing molecular behavior through its sphingolipid structure. This compound is known for its ability to interact with specific receptors, influencing cellular signaling pathways. Its unique stereochemistry contributes to selective binding, enhancing its role in lipid metabolism. The compound's hydrophilic and hydrophobic regions facilitate membrane interactions, impacting its reactivity and stability in biological systems. | ||||||
FTY720 Phosphate | 402615-91-2 | sc-205332 sc-205332A | 1 mg 5 mg | $177.00 $809.00 | 6 | |
FTY720 Phosphate, an EDG-3 compound, showcases distinctive molecular characteristics through its phosphorylated sphingosine backbone. This structure enables it to engage in specific hydrogen bonding and electrostatic interactions, influencing its solubility and reactivity. The compound's dynamic conformation allows for versatile interactions with lipid bilayers, affecting membrane fluidity and permeability. Its unique properties contribute to its role in modulating cellular responses and signaling cascades. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin can activate adenylate cyclase, increasing cAMP levels, which may trigger a signaling cascade that leads to the upregulation of EDG-3 expression. | ||||||
FTY720 (S)-Phosphate | 402616-26-6 | sc-205331 sc-205331A | 500 µg 1 mg | $113.00 $218.00 | 3 | |
FTY720 (S)-Phosphate, classified as an EDG-3 compound, features a phosphoryl group that enhances its polar character, facilitating strong ionic interactions with surrounding molecules. This compound exhibits unique reactivity patterns, particularly in its ability to form stable complexes with metal ions, which can influence catalytic pathways. Its amphiphilic nature allows it to integrate into lipid environments, altering membrane dynamics and impacting molecular transport processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C, which could initiate transcriptional events increasing EDG-3 levels. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can influence G-protein-coupled receptor signaling and may affect the expression of EDG-3 through modulation of signaling pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid, through its receptors, can modulate gene expression and potentially upregulate EDG-3 by influencing cell differentiation pathways. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
Cholecalciferol (Vitamin D3), through its hormonal activity, may regulate the expression of various G-protein-coupled receptors, including EDG-3. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $102.00 $423.00 | ||
EPA is known to modify inflammatory processes and may alter the expression of EDG-3 by modulating lipid signaling pathways. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone, a glucocorticoid, may influence EDG-3 expression through the glucocorticoid response elements in the gene's promoter region. | ||||||